YouTube and Snap Settle School District Mental Health Lawsuit Ahead of Major Social Media Trial 
Amazon Faces Class-Action Lawsuit Over Trump Tariff Price Hikes 
Samsung, Union Edge Closer to Deal as Strike Threat Looms 
SpaceX Shareholders Approve 5-for-1 Stock Split Ahead of Potential IPO 
Warren Buffett and Stephen Curry Charity Dinner Auction Raises $27 Million for Nonprofits 
OpenAI Wins Elon Musk Lawsuit as Jury Rejects Claims Over AI Mission 
Anthropic to Brief Financial Stability Board on AI-Driven Cyber Risks 
TSMC Stake Sale Sends Vanguard Semiconductor Shares Lower 
Standard Chartered Appoints Manus Costello as New CFO Amid Leadership Reshuffle 
FTC Antitrust Probe Targets Arm Holdings Over Chip Licensing Practices 
DOJ May Drop Gautam Adani Fraud Charges Amid $10 Billion U.S. Investment Plan 
Analog Devices Nears $1.5B Acquisition of AI Chip Firm Empower Semiconductor 
US-China Trade Talks Sideline Chip Export Controls as Nvidia China Sales Draw Attention 
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 
Google, Blackstone Launch $5B AI Cloud Venture to Challenge Nvidia and CoreWeave 
Berkshire Hathaway Reveals New Stakes in Delta Air Lines and Macy’s Under Greg Abel 
Applied Materials Forecasts Strong Q3 Revenue as AI Chip Demand Accelerates 
BURLINGTON, Mass., Sept. 20, 2016 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will participate in the 2016 Dougherty & Co. Institutional Investor Conference on Wednesday, September 28, 2016 at the Millennium Hotel in Minneapolis, MN.
For more information or to register, please visit the conference website at www.doughertymarkets.com.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Steven Chehames Investor Relations Coordinator +1-781-425-1659 [email protected] http://www.lemaitre.com
